Axios Pro Exclusive ContentIllustration: Shoshana Gordon/AxiosClearwater Analytics (NYSE: CWAN) agreed to acquire Enfusion (NYSE: ENFN), a SaaS provider for hedge funds and investment managers, in a cash-and-stock deal valued at $1.5 billion.Why it matters: The deal combines Clearwater's middle- and back-office tools with Enfusion's front-office product, creating an end-to-end platform.Zoom in: Enfusion shareholders will receive $11.25 per share, which includes $5.85 in cash and $5.45 in Clearwa...